Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Immunovant Inc (IMVT)

Immunovant Inc (IMVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,336,070
  • Shares Outstanding, K 169,861
  • Annual Sales, $ 0 K
  • Annual Income, $ -259,340 K
  • EBIT $ -405 M
  • EBITDA $ -405 M
  • 60-Month Beta 0.68
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 9.48

Options Overview Details

View History
  • Implied Volatility 64.26% ( +2.76%)
  • Historical Volatility 54.20%
  • IV Percentile 29%
  • IV Rank 30.95%
  • IV High 159.16% on 03/03/25
  • IV Low 21.73% on 08/23/24
  • Put/Call Vol Ratio 2.66
  • Today's Volume 1,461
  • Volume Avg (30-Day) 1,694
  • Put/Call OI Ratio 1.02
  • Today's Open Interest 59,278
  • Open Int (30-Day) 51,458

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.72
  • Number of Estimates 10
  • High Estimate -0.56
  • Low Estimate -0.86
  • Prior Year -0.52
  • Growth Rate Est. (year over year) -38.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.01 +15.46%
on 03/19/25
21.36 -8.05%
on 02/24/25
-1.63 (-7.66%)
since 02/21/25
3-Month
17.01 +15.46%
on 03/19/25
26.46 -25.77%
on 12/26/24
-6.22 (-24.05%)
since 12/20/24
52-Week
17.01 +15.46%
on 03/19/25
34.47 -43.02%
on 09/06/24
-13.45 (-40.65%)
since 03/21/24

Most Recent Stories

More News
Immunovant Announces Positive Results for Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Studies

IMVT : 19.64 (-0.25%)
Immunovant to Host Investor Webcast at 8:00 AM ET on Wednesday, March 19 to Review Results from Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Programs

IMVT : 19.64 (-0.25%)
Immunovant Reports Financial Results for the Quarter Ended December 31, 2024

IMVT : 19.64 (-0.25%)
Immunovant Announces $450 Million Private Placement

IMVT : 19.64 (-0.25%)
Insider Sale: Chief Legal Officer of $IMVT (IMVT) Sells 3,650 Shares

Mark S. Levine, the Chief Legal Officer of $IMVT ($IMVT), sold 3,650 shares of the company on 11-20-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.1% of...

IMVT : 19.64 (-0.25%)
Immunovant Provides Development Updates and Reports Financial Results for the Quarter Ended September 30, 2024

IMVT : 19.64 (-0.25%)
Immunovant Announces Oral Presentation of Late Breaking Abstract for Phase 2 Graves’ Disease Clinical Data at the 2024 American Thyroid Association (ATA) Annual Meeting

IMVT : 19.64 (-0.25%)
5 Biotech Stocks That Could Be Big Winners in 2024 and Beyond

These five biotech companies could have a lot of room to run.

AMGN : 316.04 (+0.32%)
ARGX : 615.02 (+0.32%)
BGNE : 184.71 (+0.49%)
CRSP : 41.22 (+0.12%)
IMVT : 19.64 (-0.25%)
Why Immunovant Stock Is Bolting Higher Today

The company may have best-in-class autoimmune disease therapy under its roof.

ARGX : 615.02 (+0.32%)
JNJ : 163.63 (+0.37%)
IMVT : 19.64 (-0.25%)
ROIV : 10.79 (-1.64%)
Stocks Tumble as Confidence in the U.S. Economic Outlook Wanes

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -1.47%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed...

$SPX : 5,667.56 (+0.08%)
SPY : 563.98 (+0.03%)
$DOWI : 41,985.35 (+0.08%)
DIA : 419.62 (+0.07%)
$IUXX : 19,753.97 (+0.39%)
QQQ : 480.84 (+0.33%)
CTAS : 191.17 (-1.69%)
AMZN : 196.21 (+0.65%)
AAPL : 218.27 (+1.95%)
GOOGL : 163.99 (+0.73%)
MSFT : 391.26 (+1.14%)
META : 596.25 (+1.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Immunovant, Inc. is a clinical-stage biopharmaceutical company, which develops monoclonal antibodies for the treatment of autoimmune diseases. It is developing batoclimab, a novel, fully-human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor. The...

See More

Key Turning Points

3rd Resistance Point 20.64
2nd Resistance Point 20.19
1st Resistance Point 19.92
Last Price 19.64
1st Support Level 19.20
2nd Support Level 18.75
3rd Support Level 18.48

See More

52-Week High 34.47
Fibonacci 61.8% 27.80
Fibonacci 50% 25.74
Fibonacci 38.2% 23.68
Last Price 19.64
52-Week Low 17.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar